Literature DB >> 17947233

Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4.

Deepali Bhandari1, JoAnn Trejo, Jeffrey L Benovic, Adriano Marchese.   

Abstract

The chemokine receptor CXCR4 is rapidly targeted for lysosomal degradation by the E3 ubiquitin ligase atrophin-interacting protein 4 (AIP4). Although it is known that AIP4 mediates ubiquitination and degradation of CXCR4 and that perturbations in these events contribute to disease, the mechanisms mediating AIP4-dependent regulation of CXCR4 degradation remain poorly understood. Here we show that AIP4 directly interacts with the amino-terminal half of nonvisual arrestin-2 via its WW domains. We show that depletion of arrestin-2 by small interfering RNA blocks agonist-promoted degradation of CXCR4 by preventing CXCR4 trafficking from early endosomes to lysosomes. Surprisingly, CXCR4 internalization and ubiquitination remain intact, suggesting that the interaction between arrestin-2 and AIP4 is not required for ubiquitination of the receptor at the plasma membrane but perhaps for a later post-internalization event. Accordingly, we show that activation of CXCR4 promotes the interaction between AIP4 and arrestin-2 that is consistent with a time when AIP4 co-localizes with arrestin-2 on endocytic vesicles. Taken together, our data suggest that the AIP4.arrestin-2 complex functions on endosomes to regulate sorting of CXCR4 into the degradative pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17947233     DOI: 10.1074/jbc.M705085200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  100 in total

1.  Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling.

Authors:  Rohit Malik; Unice J K Soh; JoAnn Trejo; Adriano Marchese
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 2.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

Review 3.  β-Arrestins: multifunctional signaling adaptors in type 2 diabetes.

Authors:  Xiaotao Feng; Wenjian Wang; Jibo Liu; Yi Liu
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

Review 4.  Extensive shape shifting underlies functional versatility of arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Curr Opin Cell Biol       Date:  2013-11-16       Impact factor: 8.382

Review 5.  Role of β-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking.

Authors:  Dong Soo Kang; Xufan Tian; Jeffrey L Benovic
Journal:  Curr Opin Cell Biol       Date:  2013-12-14       Impact factor: 8.382

Review 6.  Endocytic trafficking of chemokine receptors.

Authors:  Adriano Marchese
Journal:  Curr Opin Cell Biol       Date:  2013-12-14       Impact factor: 8.382

7.  Heterologous regulation of CXCR4 lysosomal trafficking.

Authors:  Adriana Caballero; Sarah A Mahn; Mudassir S Ali; M Rose Rogers; Adriano Marchese
Journal:  J Biol Chem       Date:  2019-04-01       Impact factor: 5.157

8.  The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome.

Authors:  Ilana Berlin; Katherine M Higginbotham; Rebecca S Dise; Maria I Sierra; Piers D Nash
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

9.  Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation.

Authors:  Chad E Groer; Cullen L Schmid; Alex M Jaeger; Laura M Bohn
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

Review 10.  Endo-lysosomal sorting of G-protein-coupled receptors by ubiquitin: Diverse pathways for G-protein-coupled receptor destruction and beyond.

Authors:  Michael R Dores; JoAnn Trejo
Journal:  Traffic       Date:  2018-11-18       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.